Horizon Technology Finance Boosts Innovative Treatment
Horizon Technology Finance Corporation (NASDAQ: HRZN) has just announced a major $35 million venture loan facility aimed at supporting GT Medical Technologies, Inc. This financial backing is crucial for the company's groundbreaking work in treating brain tumors with cutting-edge technology. To begin with, GT MedTech has already accessed $15 million of this loan, emphasizing the financial resources needed to scale its operations effectively.
GT Medical Technologies and Its Groundbreaking Solution
GT Medical Technologies is making waves with its signature product, GammaTile, which is set to transform the approach to brain tumor treatment. This innovative solution uses bioresorbable collagen tiles that contain Cesium-131 radiation seeds, allowing for targeted therapy right at the tumor site. Unlike traditional external radiation treatments, this method significantly reduces radiation exposure to the surrounding healthy tissues, thus improving treatment effectiveness.
Investors and Growth Strategy
GT MedTech has secured a strong group of investors, including MVM Partners, Glide Healthcare Partners, MedTech Venture Partners, and BlueStone Venture Partners. With financial support from Horizon, the company plans to bolster its operational capabilities and pursue essential market expansion efforts, which are vital to their growth plans.
Leadership Perspectives
Gerald A. Michaud, the President of Horizon Technology Finance, shared his enthusiasm about the partnership, stating, “GT MedTech is pioneering brain tumor treatment with its FDA-cleared GammaTile. This solution will help transform the standard of care while providing a cost-effective reimbursement profile to hospitals, creating a win-win for everyone involved in the healthcare ecosystem.”
Per Langoe, the Chief Executive Officer of GT MedTech, expressed excitement about the collaboration, saying, “By delivering targeted radiation immediately after tumor removal, GammaTile offers focused treatment to the tumor cavity, aiding in the destruction of remaining tumor cells. Our partnership with Horizon Technology Finance will empower us to advance our strategic commercial and market expansion goals.”
What Makes GammaTile Unique?
The FDA's clearance of GammaTile underscores its innovative method for treating patients with newly diagnosed and recurrent malignant intracranial tumors. Since its market launch, GammaTile has been embraced by over 100 leading healthcare institutions nationwide, with new centers consistently adopting it into their treatment routines.
Overview of Horizon Technology Finance
Horizon Technology Finance Corporation specializes in offering secured loans to ventures in technology, life sciences, healthcare, and sustainability sectors. By partnering with innovative companies like GT Medical Technologies, it not only addresses their financing needs but also encourages advancements that can profoundly impact patient care. Based in Farmington, Connecticut, Horizon has a strong presence with investment professionals throughout the U.S.
Frequently Asked Questions
What is the purpose of the $35 million loan to GT Medical Technologies?
This loan aims to support GT Medical Technologies' growth, specifically in expanding their innovative GammaTile product to more healthcare facilities.
How does GammaTile work in treating brain tumors?
GammaTile uses bioresorbable collagen tiles infused with radiation seeds to deliver targeted radiation directly to the tumor cavity, reducing exposure to surrounding healthy tissues.
Who are the key investors backing GT Medical Technologies?
GT Medical Technologies has received support from notable investors including MVM Partners, Glide Healthcare Partners, MedTech Venture Partners, and BlueStone Venture Partners.
What are the benefits of partnering with Horizon Technology Finance?
Horizon supplies crucial capital that enables GT Medical Technologies to concentrate on strategic growth and expand their market presence through innovative treatment options.
What areas does Horizon Technology Finance focus its investments on?
Horizon Technology Finance specializes in providing secured loans to venture-backed companies in technology, life sciences, healthcare services, and sustainability sectors.